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Supplementary Figure 1: Influences on telomere content. (a) Correlation of control telomere 13 
content and the patient age at diagnosis. (b) Correlation of telomere content in the tumor and the 14 
control sample.  15 
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Supplementary Figure 2: Structural variations upstream of TERT. (a) Distance of structural 18 
variations (SVs) up to 1 mb upstream of the TERT transcription start site (TSS). For each tumor 19 
sample, only the SV closest to the TSS is shown. Direct overlaps of juxtaposed positions with 20 
dbSUPER enhancer regions are indicated in red. dbSUPER enhancers upstream of the SV are shown 21 
in blue, where the first point of each line is the position of the SV and the second point is the 22 
rearranged enhancer position. All tumor samples with SVs within 20 kb of the TERT TSS (orange line) 23 
were considered as TERTmod for the further analysis. (b) Number of samples per tumor type with and 24 
without an SV within 20 kb of the TERT TSS. Only tumor types with at least one affected sample are 25 
shown. 26 
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Supplementary Figure 3: TMM-associated mutations and TERT expression in different tumor 29 
types. (a) Number of samples with TMM-associated mutations. Wild type tumors (i.e. tumors without 30 
TERTmod or mutation in ATRX or DAXX) were divided into those with a coverage of at least 10 reads 31 
at TERT promoter positions chr5:1,295,228 and chr5:1,295,250 (Wild typehigh cov) and those without 32 
(Wild typelow cov). The tumor types are sorted by the frequency of ATRX/DAXXtrunc and TERTmod 33 
samples. (b) Frequency of TMM-associated mutations. Wild type tumors with low coverage at the 34 
TERT promoter were excluded. (c) TERT expression in different tumor types. The tumor types are 35 
sorted by increasing median TERT expression. The center line of the boxplot is the median, 36 
the bounds of the box represent the first and third quartiles, the upper and lower whiskers extend from 37 
the hinge to the largest or smallest value, respectively, no further than 1.5 * IQR from the hinge (where 38 
IQR is the inter-quartile range, or distance between the first and third quartiles).  39 
 
 40 
Supplementary Figure 4: Telomere content and TERT expression of tumor samples with 41 
different TMM-associated mutations. (a) Telomere content tumor/control log2 ratios. (b) TERT 42 
expression in FPKMs. The center line of the boxplot is the median, the bounds of the box represent 43 
the first and third quartiles, the upper and lower whiskers extend from the hinge to the largest or 44 
smallest value, respectively, no further than 1.5 * IQR from the hinge (where IQR is the inter-quartile 45 




Supplementary Figure 5: Co-occurrence of telomere insertions, breakage-fusion-bridge (BFB) 50 
cycles and chromothripsis on the same chromosome arm. Autosomal chromosome arms of 51 
patients with different TMM-associated mutations were divided into those with indication of BFB 52 
cycles, chromothripsis, both or none of these complex structural abnormalities. The frequency of 53 
telomere insertion counts is shown for each of the classes. The total number of chromosome arms 54 
falling into each category (n) and the mean number of telomere insertions is indicated. 55 
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Supplementary Figure 6: Chromosomal positions of telomere insertions. Telomere insertions of 57 







Supplementary Figure 7: Patterns of microhomology at telomere insertions. The number of 65 
homologous bases between the canonical TTAGGG telomere repeat and the human reference 66 
genome at telomere insertions is shown on the x-axis. The number of telomere insertions with a 67 
pattern of TTAGGG microhomology (red), blunt-end DNA joining (yellow) or without TTAGGG repeats 68 
at the junction site (green) are shown on the y-axis. 69 
 70 





Supplementary Figure 8: Examples of one-sided telomere insertions without annotated 75 
accompanying structural variations. (a) Subclonal telomere insertion in pancreatic endocrine tumor 76 
sample SP102547 (copy number at position = 2; tumor purity = 0.87, as determined by copy number 77 
calls). Blue tracks show the sequencing coverage; light blue represents clipped sequences. Individual 78 
reads are grey and clipped bases are colored. Non-telomeric clipped bases are transparent. Dark grey 79 
reads represent the non-telomeric end of a discordant read pair. (b) Unannotated structural variation 80 
(position 23,228,785; opaque non-telomeric clipped reads) opposite of a telomere insertion (position 81 






Supplementary Figure 9: TERRA expression in tumor samples with different TMM-associated 88 
mutations. The samples are colored by the number of TERRA reads mapping to telomere insertions 89 
sites. The center line of the boxplot is the median, the bounds of the box represent the first and third 90 
quartiles, the upper and lower whiskers extend from the hinge to the largest or smallest value, 91 
respectively, no further than 1.5 * IQR from the hinge (where IQR is the inter-quartile range, or 92 
distance between the first and third quartiles). ****p < 0.0001, Wilcoxon rank-sum test. 93 
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95 
Supplementary Figure 10: Frequency of TVRs in arbitrary context. The mean pattern counts per 96 
telomere read are shown for all tumor samples. TVRs shown in red were investigated further 97 
regarding sequence context. The center line of the boxplot is the median, the bounds of the box 98 
represent the first and third quartiles, the upper and lower whiskers extend from the hinge to the 99 
largest or smallest value, respectively, no further than 1.5 * IQR from the hinge (where IQR is the 100 
inter-quartile range, or distance between the first and third quartiles). 101 




Supplementary Figure 11: The neighborhood of TVRs is indicative of the telomere maintenance 105 
mechanism. (a) Receiver operating characteristic for the classification of samples with ALT-106 
associated mutations from telomere variant repeats. Red: no specific sequence context required. Blue: 107 
singletons ((TTAGGG)3-NNNGGG-(TTAGGG)3). (b) Area under the curve (AUC) for the classification 108 
of ALT using repeat type counts in different sequence context.  109 
 
110 
Supplementary Figure 12: Raw counts of singleton TVRs across all samples. Singleton counts 111 
are shown in log scale for all tumor and control samples. A pseudocount of 0.1 was added. The center 112 
line of the boxplot is the median, the bounds of the box represent the first and third quartiles, the upper 113 
and lower whiskers extend from the hinge to the largest or smallest value, respectively, no further than 114 





Supplementary Figure 13: Singleton TVRs. (a) Pattern count tumor/control log2 ratios of all patients 120 
plotted against telomere content tumor/control log2 ratios for analyzed singletons. The regression line 121 
through the TERTmod samples is shown in green and is defined as the expected pattern count. 122 
(b) Distance to the expected singleton repeat count in ATRX/DAXXtrunc and TERTmod samples. The 123 
center line of the boxplot is the median, the bounds of the box represent the first and third quartiles, 124 
the upper and lower whiskers extend from the hinge to the largest or smallest value, respectively, no 125 
further than 1.5 * IQR from the hinge (where IQR is the inter-quartile range, or distance between the 126 
first and third quartiles). ****p < 0.0001; ***p < 0.001; ns = not significant, Wilcoxon rank-sum tests 127 
after Bonferroni correction.   128 
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Supplementary Figure 14: Correlation of singleton TVRs in ATRX/DAXXtrunc samples. The 131 
Spearman correlation coefficients for the occurrence of the significantly enriched/depleted singleton 132 








Supplementary Figure 15: Clustering by singleton TVR occurrences. The heatmap depicts the 140 
difference of observed singleton occurrence to the expected occurrence (columns) for tumor samples 141 
with TERTmod and/or mutations in ATRX or DAXX (rows). The TMM-associated mutations, telomere 142 
content tumor/control (log2), percent of breakpoints with telomere insertion and tumor type are 143 




Supplementary Figure 16: ALT probability of tumor samples with different TMM-associated 147 
mutations. The ALT probability was derived from a random forest classifier trained to distinguish 148 
ATRX/DAXXtrunc from TERTmod samples based on the following features: telomere content 149 
tumor/control log2 ratio, number of telomere insertions, number of break points and the distance of 150 
TGAGGG, TCAGGG, TTGGGG, TTCGGG and TTTGGG singletons to their expected occurrence. 151 
The classifier was only applied to samples without missing data. The center line of the boxplot is the 152 
median, the bounds of the box represent the first and third quartiles, the upper and lower whiskers 153 
extend from the hinge to the largest or smallest value, respectively, no further than 1.5 * IQR from the 154 





Supplementary Figure 17: Prediction of ALT probability in different tumor types. For each tumor 160 
sample, the ALT probability predicted by a random forest classifier is shown. The tumor types are 161 
ordered by mean telomere content tumor/control log2 ratio (from left to right). Cohorts with sample 162 
sizes below 15 are not shown. 163 
164 
 
Supplementary Table 1: Mutated genes significantly associated with telomere insertions. The 165 
genes were obtained from correlation analysis of telomere insertions and mutations of genes from the 166 
TelNet database. q-values were calculated with Wilcoxon rank-sum tests with Benjamini-Hochberg 167 
correction.  168 
 169 
Gene q-value Association with telomeres/telomere maintenance 
TP53 1.9 × 10-42 Co-mutations of the tumor suppressor gene TP53 with ATRX and H3F3A 
were found in pediatric glioblastoma1. p53 was also found to inhibit 




2.6 × 10-6 / 
0.019 
The death domain-associated protein DAXX and the chromatin 
remodeling factor ATRX (a-thalassemia/mental retardation syndrome 
protein) are specifically associated with the H3.3 deposition machinery. 
The loss of function of ATRX and/or DAXX correlates with the ALT 
phenotype4-7. 
PLCB2 7.8 × 10-4 The yeast homologue of PLCB2, PLC1, was found in a TLC1 knock out 
study8. 
MEN1 0.017 The tumor suppressor menin, encoded by MEN1, was reported to 
negatively regulate telomerase by binding to the TERT promotor9, while 
siRNA-based inhibition of MEN1 does not lead to the up-regulation of 
hTERT mRNA expression10. A germline mutation in MEN1 predisposed 
to developing pancreatic neuroendocrine tumors. In a study of 50 patient 
samples, 6% of this tumor entity show loss of ATRX and/or DAXX 
expression and activation of ALT6. Also, it was found to inversely be 
associated with telomere length11. In agreement with this, mutations in 
MEN1 were associated with increased telomere length in pancreatic 
endocrine neoplasms12. 
TSSC4 0.017 TSSC4 was found in close proximity to RAP1 by a PCA/BiFC assay13. 
RB1 0.018 The tumor suppressor RB1 was predicted to be potentially involved in 
telomere maintenance by Lovejoy et al. because it is part of the DNA 
damage response machinery5. Gonzalez-Vasconcellos et al. showed that 
both telomeric chromatin compaction and telomeric repeat-containing 
containing RNA (TERRA) transcription are dependent on RB1 
expression14.  
ABCC8 0.04 The yeast homologue of ABCC8, YOR1, was found in two independent 
deletions screens in S. cerevisiae8,15. 
 170 
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Supplementary Table 2: Prevalence of ALT-like telomere composition in different tumor types. 172 
Tumor samples were considered to have an ALT-like telomere composition if the difference of the 173 
TGAGGG, TCAGGG, TTGGGG or TTCGGG singleton occurrence to the expected occurrence was 174 
larger than 2.5, or if the difference of the TTTGGG occurrence in t-type context to the expected 175 
occurrence was lower than -2. 176 
 177 
Tumor type n/N %
SoftTissue-Leiomyo 9/15 60 
Panc-Endocrine 34/81 42 
SoftTissue-Liposarc 7/19 37 
Bone-Osteosarc 10/35 29 
CNS-LGG 5/18 28 
CNS-GBM 5/39 13 
Bone-Epith 1/10 10 
Kidney-ChRCC 3/43 7 
Skin-Melanoma 8/107 7 
Bone-Benign 1/16 6 
Liver-HCC 14/305 5 
Uterus-AdenoCA 2/44 5 
CNS-Medullo 6/141 4 
ColoRect-AdenoCA 2/52 4 
Biliary-AdenoCA 1/33 3 
Kidney-RCC 4/143 3 
Eso-AdenoCA 2/97 2 
Lymph-BNHL 2/107 2 
Lymph-CLL 2/90 2 
Ovary-AdenoCA 2/110 2 
Breast-AdenoCA 1/195 1 
Panc-AdenoCA 2/229 1 
Prost-AdenoCA 2/178 1 
Bladder-TCC 0/23 0 
Breast-DCIS 0/3 0 
Breast-LobularCA 0/13 0 
Cervix-AdenoCA 0/2 0 
Cervix-SCC 0/18 0 
CNS-PiloAstro 0/89 0 
Head-SCC 0/56 0 
Lung-AdenoCA 0/37 0 
Lung-SCC 0/47 0 
Myeloid-AML 0/8 0 
Stomach-AdenoCA 0/68 0 
Thy-AdenoCA 0/48 0 
 178 
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Supplementary Table 3: Feature importance in random forest classifier trained on 180 
ATRX/DAXXtrunc and TERTmod tumor samples. 181 
 182 
Feature Importance 
TTTGGG singleton divergence to expected count 13.59 
TTCGGG singleton divergence to expected count   11.92 
breakpoint count 11.01 
telomere insertion count  10.03 
telomere content tumor/control log2 ratio 5.34 
TGAGGG singleton divergence to expected count 5.02 
TCAGGG singleton divergence to expected count 3.25 
TTGGGG singleton divergence to expected count 2.83 
 183 
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Supplementary Table 4: Histology overview. Information on the tumor types included in this study. 185 
 186 
Abbreviation Organ Included subtypes 
Biliary-AdenoCA Biliary Cholangiocarcinoma; Cholangiocarcinoma, papillary 
Bladder-TCC Bladder Transitional cell carcinoma; Transitional cell carcinoma, papillary 
Bone-Benign Bone/SoftTissue Osteoblastoma; Osteofibrous dysplasia; Chondroblastoma; 
Chrondromyxoid fibroma 
Bone-Epith Bone/SoftTissue Adamantinoma; Chordoma 
Bone-Osteosarc Bone/SoftTissue Osteosarcoma 
Breast-AdenoCA Breast Infiltrating duct carcinoma; Intraductal papillary adenocarcinoma 
with invasion; Medullary carcinonoma; Mucinous adenocarcinoma 
Breast-DCIS Breast Duct micropapillary carcinoma 
Breast-LobularCA Breast Lobular carcinoma 
Cervix-AdenoCA Cervix Adenocarcinoma 
Cervix-SCC Cervix Squamous Cell Carcinoma 
CNS-GBM CNS Glioblastoma 
CNS-LGG CNS Oligodendroglioma; ATRX-mutant, 1p/19q-intact lower grade 
gliomas 
CNS-Medullo CNS Desmoplastic medulloblastoma; Large cell medulloblastoma; 
Medulloblastoma 
CNS-PiloAstro CNS Pilocytic astrocytoma 
ColoRect-AdenoCA Colon/Rectum Adenocarcinoma; Adenocarcinoma, mucinous; Mucinous 
adenocarcinoma 
Eso-AdenoCA Esophagus Adenocarcinoma 
Head-SCC Head/Neck Squamous cell carcinoma 
Kidney-ChRCC Kidney Adenocarcinoma, chromophobe type 
Kidney-RCC Kidney Adenocarcinoma, clear cell type; Adenocarcinoma, papillary type 
Liver-HCC Liver Combined hepatocellular + cholangiocarcinoma; Fibrolamellar 
hepatocellular carcinoma; Hepatocellular carcinoma 
Lung-AdenoCA Lung Adenocarcinoma, in situ; Adenocarcinoma, invasive; 
Adenocarcinoma, invasive, mucinous 
Lung-SCC Lung Basaloid squamous cell carcinoma; Squamous cell carcinoma 
Lymph-BNHL Lymphoid Burkitt lymphoma; Diffuse large B-cell lymphoma; Follicular 
lymphoma; Marginal zone B-cell lymphoma; Post-transplant 
lymphoproliferative disorder, early lesion 
Lymph-CLL Lymphoid Chronic lymphocytic leukemia 
Myeloid-AML Myeloid Acute myeloid leukemia 
Ovary-AdenoCA Ovary Adenocarcinoma; Serous cystadenocarcinoma 
Panc-AdenoCA Pancreas Acinar cell carcinoma; Adenocarcinoma; Adenocarcinoma, 
mucinous; Carcinoma, adenosquamous; Invasive carcinoma arising 
in IPMN; Pancreatic ductal carcinoma 
Panc-Endocrine Pancreas Neuroendocrine carcinoma 
Prost-AdenoCA Prostate Adenocarcinoma 
Skin-Melanoma Skin Malignant melanoma 
SoftTissue-Leiomyo Bone/SoftTissue Leiomyosarcoma 
SoftTissue-Liposarc Bone/SoftTissue Liposarcoma 
Stomach-AdenoCA Stomach Adenocarcinoma; Adenocarcinoma, mucinous; Adenocarcinoma, 
papillary; Adenocarcinoma, poorly cohesive; Adenocarcinoma, 
tubular 
Thy-AdenoCA Thyroid Adenocarcinoma, classical type; Adenocarcinoma, columnar cell 
type; Adenocarcinoma, follicular type 
Uterus-AdenoCA Uterus Adenocarcinoma, endometrioid; Serous cystadenocarcinoma 
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